Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Needham raised Okta, Inc. (NASDAQ:OKTA) price target from $115 to $125. Needham analyst Mike Cikos maintained a Buy rating. Okta shares closed at $125.50 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. raised the price target for Franco-Nevada Corporation (NYSE:FNV) from $180 to $195. HC Wainwright & Co. analyst Heiko Ihle maintained a Buy rating. Franco-Nevada shares closed at $168.24 on Tuesday. See how other analysts view this stock.
- Jefferies cut Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) price target from $29 to $2.5. Jefferies analyst Andrew Tsai downgraded the stock from Buy to Hold. Rocket Pharmaceuticals shares closed at $2.33 on Tuesday. See how other analysts view this …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Needham raised Okta, Inc. (NASDAQ:OKTA) price target from $115 to $125. Needham analyst Mike Cikos maintained a Buy rating. Okta shares closed at $125.50 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. raised the price target for Franco-Nevada Corporation (NYSE:FNV) from $180 to $195. HC Wainwright & Co. analyst Heiko Ihle maintained a Buy rating. Franco-Nevada shares closed at $168.24 on Tuesday. See how other analysts view this stock.
- Jefferies cut Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) price target from $29 to $2.5. Jefferies analyst Andrew Tsai downgraded the stock from Buy to Hold. Rocket Pharmaceuticals shares closed at $2.33 on Tuesday. See how other analysts view this …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Needham raised Okta, Inc. (NASDAQ:OKTA) price target from $115 to $125. Needham analyst Mike Cikos maintained a Buy rating. Okta shares closed at $125.50 on Tuesday. See how other analysts view this stock.
HC Wainwright & Co. raised the price target for Franco-Nevada Corporation (NYSE:FNV) from $180 to $195. HC Wainwright & Co. analyst Heiko Ihle maintained a Buy rating. Franco-Nevada shares closed at $168.24 on Tuesday. See how other analysts view this stock.
Jefferies cut Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) price target from $29 to $2.5. Jefferies analyst Andrew Tsai downgraded the stock from Buy to Hold. Rocket Pharmaceuticals shares closed at $2.33 on Tuesday. See how other analysts view this …Full story available on Benzinga.com Read Moreanalysts forecasts, BAER, BBDC, CLGN, CRM, FNV, News, OKTA, PRTA, PT Changes, PTCT, RCKT, RUN, RWAY, TGT, WMB, Price Target, Markets, Analyst Ratings, Trading Ideas, CRM, US79466L3024, TGT, US87612E1064, WMB, US9694571004, FNV, PRTA, PTCT, RUN, OKTA, CLGN, BBDC, RCKT, RWAY, BAER, News, Price Target, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
